Author:
Halama Anna,Suleiman Noor N.,Kulinski Michal,Bettahi Ilham,Hassoun Shaimaa,Alkasem Meis,Abdalhakam Ibrahem,Iskandarani Ahmad,Samra Tareq A.,Atkin Stephen L.,Suhre Karsten,Abou-Samra Abdul Badi
Abstract
AbstractMetabolic pathways that are corrupted at early stages of insulin resistance (IR) remain elusive. This study investigates changes in body metabolism in clinically healthy and otherwise asymptomatic subjects that may become apparent already under compromised insulin sensitivity (IS) and prior to IR. 47 clinically healthy Arab male subjects with a broad range of IS, determined by hyperinsulinemic-euglycemic clamp (HIEC), were investigated. Untargeted metabolomics and complex lipidomics were conducted on serum samples collected under fasting and HIEC conditions. Linear models were used to identify associations between metabolites concentrations and IS levels. Among 1896 identified metabolites, 551 showed significant differences between fasting and HIEC, reflecting the metabolic switch in energy utilization. At fasting, 336 metabolites, predominantly di- and tri-acylglycerols, showed significant differences between subjects with low and high levels of IS. Changes in amino acid, carbohydrate and fatty acid metabolism in response to insulin were impaired in subjects with low IS. Association of altered mannose and amino acids with IS was also replicated in an independent cohort of T2D patients. We identified metabolic phenotypes that characterize clinically healthy Arab subjects with low levels of IS at their fasting state. Our study is providing further insights into the metabolic pathways that precede IR.
Funder
Qatar National Research Fund
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Bloomgarden, Z. T. Insulin resistance concepts. Diabetes Care 30, 1320–1326 (2007).
2. Abuyassin, B. & Laher, I. Diabetes epidemic sweeping the Arab world. World J. Diabetes 7, 165 (2016).
3. Taheri, S. et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): An open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 8, 477–489 (2020).
4. Tam, C. S. et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35, 1605–1610 (2012).
5. DeFronzo, R. A., Tobin, J. D. & Andres, R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am. J. Physiol. Metab. 237, E214 (1979).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献